June 22 (Reuters) - Medadvisor Ltd (MDR) :
- COMPLETED A STRATEGIC REVIEW OF ITS OPERATIONS
- FY23 REVENUE EXPECTED TO BE IN RANGE OF A$95 MILLION TO A$97 MILLION
- PLANS TO REDUCE ITS AUSTRALIAN HEADCOUNT BY APPROXIMATELY 20% BY END OF JUNE 2023
- FY 23 EBITDA LOSS EXPECTED TO BE IN RANGE A$3.5 MILLION TO A$3.0 MILLION
- REDUCTION IN HEADCOUNT UNDERPINS ANNUAL COST SAVINGS OF CIRCA A$2 MILLION FOR FY24
- HAS POSITIONED ITSELF FOR PROFITABILITY IN FY24
- COMPANY'S CURRENT US PIPELINE IS MATERIALLY ABOVE PREVIOUS CORRESPONDING PERIOD
- Forums
- ASX - By Stock
- MDR
- News: MDR Medadvisor Says Completed Strategic Review Of Its Operations
MDR
medadvisor limited
Add to My Watchlist
2.27%
!
4.5¢

News: MDR Medadvisor Says Completed Strategic Review Of Its Operations
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.5¢ |
Change
0.001(2.27%) |
Mkt cap ! $28.45M |
Open | High | Low | Value | Volume |
4.4¢ | 4.6¢ | 4.4¢ | $6.383K | 142.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 79533 | 4.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 49980 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 79533 | 0.044 |
2 | 76000 | 0.043 |
1 | 20000 | 0.042 |
1 | 50000 | 0.041 |
2 | 90000 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 49980 | 1 |
0.048 | 20000 | 1 |
0.049 | 11000 | 1 |
0.050 | 90907 | 2 |
0.052 | 19244 | 1 |
Last trade - 14.25pm 11/09/2025 (20 minute delay) ? |
Featured News
MDR (ASX) Chart |